Needham analyst Ryan MacDonald initiates coverage on Definitive Healthcare (NASDAQ:DH) with a Buy rating and announces Price Target of $30.
Citigroup’s Big Business Revamp Continues: Sells China Onshore Consumer Wealth Portfolio To HSBC
Citigroup Inc (NYSE: C) disclosed its plan to